Skip to main content
SpringerLink
Log in

Hypertension and Chronic Kidney Disease in Asians

  • Chapter
  • First Online:
Hypertension and Cardiovascular Disease in Asia

Part of the book series: Updates in Hypertension and Cardiovascular Protection ((UHCP))

  • 702 Accesses

Abstract

Chronic kidney disease (CKD) and hypertension can cause, and are known for their associations with one another. The rising affliction with diabetes and hypertension has led to the increasing prevalence of CKD and end-stage kidney disease (ESKD). The burden of hypertension depends on many factors. Asia houses a variety of ethnic groups which plays a role in variability of socioeconomic status, dietary patterns, lifestyle habits, and attitudes to healthcare. All of which contribute to the heterogeneous prevalence of hypertension and CKD within the region, or even country, thereby emphasizing the importance of identifying gaps in healthcare and implementing crucial national strategies to control hypertension and curb CKD progression.

For this chapter, focusing on countries in Asia, we review the following: (1) epidemiology of hypertension and CKD; (2) relationship of hypertension and CKD with clinical outcomes; (3) genetics associated with hypertension and CKD; (4) impact of sodium and dietary patterns; and (5) antihypertensives prescription patterns.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kidney Disease: Improving Global Outcomes Blood Pressure Work G. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3S):S1–S87. https://doi.org/10.1016/j.kint.2020.11.003.

    Article  Google Scholar 

  2. Teo BW, Chan GC, Leo CCH, Tay JC, Chia YC, Siddique S, et al. Hypertension and chronic kidney disease in Asian populations. J Clin Hypertens (Greenwich). 2021;23(3):475–80. https://doi.org/10.1111/jch.14188.

    Article  Google Scholar 

  3. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–22. https://doi.org/10.1016/S0140-6736(12)60033-6.

    Article  PubMed  Google Scholar 

  4. Zheng Y, Tang L, Zhang W, Zhao D, Zhang D, Zhang L, et al. Applying the new intensive blood pressure categories to a nondialysis chronic kidney disease population: the Prevalence, Awareness and Treatment Rates in Chronic Kidney Disease Patients with Hypertension in China survey. Nephrol Dial Transplant. 2020;35(1):155–61. https://doi.org/10.1093/ndt/gfy301.

    Article  PubMed  Google Scholar 

  5. Surveilance and Epidemiology Branch CfHP, Department of Health, Hong Kong Special Administrative Region Government. Report of population survey 2014/2015. 2017.

    Google Scholar 

  6. Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32(6):1170–7. https://doi.org/10.1097/HJH.0000000000000146.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SR, Acharya VN, et al. Epidemiology and risk factors of chronic kidney disease in India—results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol. 2013;14:114. https://doi.org/10.1186/1471-2369-14-114.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42(9):1235–481. https://doi.org/10.1038/s41440-019-0284-9.

    Article  PubMed  Google Scholar 

  9. Chia YC, Kario K, Turana Y, Nailes J, Tay JC, Siddique S, et al. Target blood pressure and control status in Asia. J Clin Hypertens (Greenwich). 2020;22(3):344–50. https://doi.org/10.1111/jch.13714.

    Article  Google Scholar 

  10. Hooi LS, Ong LM, Ahmad G, Bavanandan S, Ahmad NA, Naidu BM, et al. A population-based study measuring the prevalence of chronic kidney disease among adults in West Malaysia. Kidney Int. 2013;84(5):1034–40. https://doi.org/10.1038/ki.2013.220.

    Article  CAS  PubMed  Google Scholar 

  11. Subramanian S, Teo BW, Toh QC, Koh YY, Li J, Sethi S, et al. Spot urine tests in predicting 24-hour urine sodium excretion in Asian patients. J Ren Nutr. 2013;23(6):450–5. https://doi.org/10.1053/j.jrn.2012.12.004.

    Article  CAS  PubMed  Google Scholar 

  12. Korean Society H, Hypertension Epidemiology Research Working G, Kim HC, Cho MC. Korea hypertension fact sheet 2018. Clin Hypertens. 2018;24:13. https://doi.org/10.1186/s40885-018-0098-0.

    Article  Google Scholar 

  13. Park JI, Baek H, Jung HH. Prevalence of chronic kidney disease in Korea: the Korean National Health and Nutritional Examination Survey 2011-2013. J Korean Med Sci. 2016;31(6):915–23. https://doi.org/10.3346/jkms.2016.31.6.915.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Health Promotion Administration, Ministry of Health and Welfare, Taiwan. Nutrition and Health Survey in Taiwan (NAHSIT) Report 2013–2016.

    Google Scholar 

  15. Cai G. Etiology, comorbidity and factors associated with renal function decline in Chinese chronic kidney disease patients. J Am Soc Nephrol. 2011;22:183A–4A.

    Google Scholar 

  16. Ho YW, Chau K, Choy BY, et al. Hong Kong renal registry report 2010. Hong Kong J Nephrol. 2010;12(2):81–98.

    Article  Google Scholar 

  17. Jha V. Current status of end-stage renal disease care in India and Pakistan. Kidney Int Suppl. 2013;3(2):157–60.

    Article  Google Scholar 

  18. Masakane I, Taniguchi M, Nakai S, et al. Annual dialysis data report 2016, JSDT renal data registry. Ren Replace Ther. 2018;4:45.

    Article  Google Scholar 

  19. Registry SR. First report of the Singapore renal registry 1997. 1998.

    Google Scholar 

  20. Kim YS, Jin DC. Global dialysis perspective: Korea. Kidney360. 2020;1:52–7.

    Article  Google Scholar 

  21. Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton). 2010;15(Suppl 2):3–9. https://doi.org/10.1111/j.1440-1797.2010.01304.x.

    Article  Google Scholar 

  22. Alencar de Pinho N, Levin A, Fukagawa M, Hoy WE, Pecoits-Filho R, Reichel H, et al. Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease. Kidney Int. 2019;96(4):983–94. https://doi.org/10.1016/j.kint.2019.04.032.

    Article  CAS  PubMed  Google Scholar 

  23. Sabanayagam C, Lim SC, Wong TY, Lee J, Shankar A, Tai ES. Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease. Nephrol Dial Transplant. 2010;25(8):2564–70. https://doi.org/10.1093/ndt/gfq084.

    Article  PubMed  Google Scholar 

  24. Sabanayagam C, Teo BW, Tai ES, Jafar TH, Wong TY. Ethnic differences in the association between blood pressure components and chronic kidney disease in middle aged and older Asian adults. BMC Nephrol. 2013;14:86. https://doi.org/10.1186/1471-2369-14-86.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Lew QLJ, Allen JC, Nguyen F, Tan NC, Jafar TH. Factors associated with chronic kidney disease and their clinical utility in primary care clinics in a multi-ethnic Southeast Asian population. Nephron. 2018;138(3):202–13. https://doi.org/10.1159/000485110.

    Article  PubMed  Google Scholar 

  26. Sabanayagam C, Shankar A, Lim SC, Tai ES, Wong TY. Hypertension, hypertension control, and chronic kidney disease in a Malay population in Singapore. Asia Pac J Public Health. 2011;23(6):936–45. https://doi.org/10.1177/1010539510361637.

    Article  PubMed  Google Scholar 

  27. Wan EYF, Yu EYT, Chin WY, Fong DYT, Choi EPH, Lam CLK. Association of blood pressure and risk of cardiovascular and chronic kidney disease in Hong Kong hypertensive patients. Hypertension. 2019;74(2):331–40. https://doi.org/10.1161/HYPERTENSIONAHA.119.13123.

    Article  CAS  PubMed  Google Scholar 

  28. Domrongkitchaiporn S, Sritara P, Kitiyakara C, Stitchantrakul W, Krittaphol V, Lolekha P, et al. Risk factors for development of decreased kidney function in a Southeast Asian population: a 12-year cohort study. J Am Soc Nephrol. 2005;16(3):791–9. https://doi.org/10.1681/ASN.2004030208.

    Article  PubMed  Google Scholar 

  29. Jiang C, Wang B, Li Y, Xie L, Zhang X, Wang J, et al. U-shaped association between serum albumin and development of chronic kidney disease in general hypertensive patients. Clin Nutr. 2020;39(1):258–64. https://doi.org/10.1016/j.clnu.2019.02.002.

    Article  CAS  PubMed  Google Scholar 

  30. Yano Y, Fujimoto S, Sato Y, Konta T, Iseki K, Iseki C, et al. New-onset hypertension and risk for chronic kidney disease in the Japanese general population. J Hypertens. 2014;32(12):2371–7.; ; discussion 7. https://doi.org/10.1097/HJH.0000000000000344.

    Article  CAS  PubMed  Google Scholar 

  31. Kang YU, Bae EH, Ma SK, Kim SW. Determinants and burden of chronic kidney disease in a high-risk population in Korea: results from a cross-sectional study. Korean J Intern Med. 2016;31(5):920–9. https://doi.org/10.3904/kjim.2014.243.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Chang TI, Lim H, Park CH, Rhee CM, Moradi H, Kalantar-Zadeh K, et al. Associations of systolic blood pressure with incident CKD G3-G5: a cohort study of South Korean adults. Am J Kidney Dis. 2020;76(2):224–32. https://doi.org/10.1053/j.ajkd.2020.01.013.

    Article  PubMed  Google Scholar 

  33. Saminathan TA, Hooi LS, Mohd Yusoff MF, Ong LM, Bavanandan S, Rodzlan Hasani WS, et al. Prevalence of chronic kidney disease and its associated factors in Malaysia; findings from a nationwide population-based cross-sectional study. BMC Nephrol. 2020;21(1):344. https://doi.org/10.1186/s12882-020-01966-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Ingsathit A, Thakkinstian A, Chaiprasert A, Sangthawan P, Gojaseni P, Kiattisunthorn K, et al. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant. 2010;25(5):1567–75. https://doi.org/10.1093/ndt/gfp669.

    Article  PubMed  Google Scholar 

  35. Yan Z, Wang Y, Li S, Wang J, Zhang L, Tan H, et al. Hypertension control in adults with CKD in China: baseline results from the Chinese cohort study of chronic kidney disease (C-STRIDE). Am J Hypertens. 2018;31(4):486–94. https://doi.org/10.1093/ajh/hpx222.

    Article  CAS  PubMed  Google Scholar 

  36. Yuan J, Zou XR, Han SP, Cheng H, Wang L, Wang JW, et al. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE). BMC Nephrol. 2017;18(1):23. https://doi.org/10.1186/s12882-017-0441-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Anupama YJ, Hegde SN, Uma G, Patil M. Hypertension is an important risk determinant for chronic kidney disease: results from a cross-sectional, observational study from a rural population in South India. J Hum Hypertens. 2017;31(5):327–32. https://doi.org/10.1038/jhh.2016.81.

    Article  CAS  PubMed  Google Scholar 

  38. Inaguma D, Imai E, Takeuchi A, Ohashi Y, Watanabe T, Nitta K, et al. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study. Clin Exp Nephrol. 2017;21(3):446–56. https://doi.org/10.1007/s10157-016-1309-1.

    Article  PubMed  Google Scholar 

  39. Li Y, Li D, Song Y, Gao L, Fan F, Wang B, et al. Visit-to-visit variability in blood pressure and the development of chronic kidney disease in treated general hypertensive patients. Nephrol Dial Transplant. 2020;35(10):1739–46. https://doi.org/10.1093/ndt/gfz093.

    Article  CAS  PubMed  Google Scholar 

  40. Li Y, Zhou H, Liu M, Liang M, Wang G, Wang B, et al. Association of visit-to-visit variability in blood pressure and first stroke risk in hypertensive patients with chronic kidney disease. J Hypertens. 2020;38(4):610–7. https://doi.org/10.1097/HJH.0000000000002306.

    Article  CAS  PubMed  Google Scholar 

  41. Hirayama A, Konta T, Kamei K, Suzuki K, Ichikawa K, Fujimoto S, et al. Blood pressure, proteinuria, and renal function decline: associations in a large community-based population. Am J Hypertens. 2015;28(9):1150–6. https://doi.org/10.1093/ajh/hpv003.

    Article  CAS  PubMed  Google Scholar 

  42. Chia YC, Lim HM, Ching SM. Long-term visit-to-visit blood pressure variability and renal function decline in patients with hypertension over 15 years. J Am Heart Assoc. 2016;5(11):e003825. https://doi.org/10.1161/JAHA.116.003825.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Cha RH, Kim S, Ae Yoon S, Ryu DR, Eun OJ, Han SY, et al. Association between blood pressure and target organ damage in patients with chronic kidney disease and hypertension: results of the APrODiTe study. Hypertens Res. 2014;37(2):172–8. https://doi.org/10.1038/hr.2013.127.

    Article  PubMed  Google Scholar 

  44. Azushima K, Wakui H, Uneda K, Haku S, Kobayashi R, Ohki K, et al. Within-visit blood pressure variability and cardiovascular risk factors in hypertensive patients with non-dialysis chronic kidney disease. Clin Exp Hypertens. 2017;39(7):665–71. https://doi.org/10.1080/10641963.2017.1313850.

    Article  PubMed  Google Scholar 

  45. Wain LV, Vaez A, Jansen R, Joehanes R, van der Most PJ, Erzurumluoglu AM, et al. Novel blood pressure locus and gene discovery using genome-wide association study and expression data sets from blood and the kidney. Hypertension. 2017. https://doi.org/10.1161/HYPERTENSIONAHA.117.09438.

  46. Wuttke M, Li Y, Li M, Sieber KB, Feitosa MF, Gorski M, et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat Genet. 2019;51(6):957–72. https://doi.org/10.1038/s41588-019-0407-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Liu L, Wang C, Mi Y, Liu D, Li L, Fan J, et al. Association of MYH9 polymorphisms with hypertension in patients with chronic kidney disease in China. Kidney Blood Press Res. 2016;41(6):956–65. https://doi.org/10.1159/000452597.

    Article  CAS  PubMed  Google Scholar 

  48. Redon J, Chaves FJ, Liao Y, Pascual JM, Rovira E, Armengod ME, et al. Influence of the I/D polymorphism of the angiotensin-converting enzyme gene on the outcome of microalbuminuria in essential hypertension. Hypertension. 2000;35(1 Pt 2):490–5. https://doi.org/10.1161/01.hyp.35.1.490.

    Article  CAS  PubMed  Google Scholar 

  49. Tripathi G, Dharmani P, Khan F, Sharma RK, Pandirikkal V, Agrawal S. High prevalence of ACE DD genotype among north Indian end stage renal disease patients. BMC Nephrol. 2006;7:15. https://doi.org/10.1186/1471-2369-7-15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Su SL, Lu KC, Lin YF, Hsu YJ, Lee PY, Yang HY, et al. Gene polymorphisms of angiotensin-converting enzyme and angiotensin II type 1 receptor among chronic kidney disease patients in a Chinese population. J Renin-Angiotensin-Aldosterone Syst. 2012;13(1):148–54. https://doi.org/10.1177/1470320311430989.

    Article  CAS  PubMed  Google Scholar 

  51. Katsuya T, Ishikawa K, Sugimoto K, Rakugi H, Ogihara T. Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res. 2003;26(7):521–5. https://doi.org/10.1291/hypres.26.521.

    Article  PubMed  Google Scholar 

  52. Lin DS, Wang TD, Buranakitjaroen P, Chen CH, Cheng HM, Chia YC, et al. Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: evidence from Asia and around the globe. J Clin Hypertens (Greenwich). 2021;23(3):556–67. https://doi.org/10.1111/jch.14120.

    Article  CAS  Google Scholar 

  53. Liu Y, Shi M, Dolan J, He J. Sodium sensitivity of blood pressure in Chinese populations. J Hum Hypertens. 2020;34(2):94–107. https://doi.org/10.1038/s41371-018-0152-0.

    Article  CAS  PubMed  Google Scholar 

  54. Liu Z, Qi H, Liu B, Liu K, Wu J, Cao H, et al. Genetic susceptibility to salt-sensitive hypertension in a Han Chinese population: a validation study of candidate genes. Hypertens Res. 2017;40(10):876–84. https://doi.org/10.1038/hr.2017.57.

    Article  CAS  PubMed  Google Scholar 

  55. Nierenberg JL, Li C, He J, Gu D, Chen J, Lu X, et al. Blood pressure genetic risk score predicts blood pressure responses to dietary sodium and potassium: The GenSalt Study (Genetic Epidemiology Network of Salt Sensitivity). Hypertension. 2017;70(6):1106–12. https://doi.org/10.1161/HYPERTENSIONAHA.117.10108.

    Article  CAS  PubMed  Google Scholar 

  56. Qi H, Liu B, Guo C, Liu Z, Cao H, Liu K, et al. Effects of environmental and genetic risk factors for salt sensitivity on blood pressure in northern China: the systemic epidemiology of salt sensitivity (EpiSS) cohort study. BMJ Open. 2018;8(12):e023042. https://doi.org/10.1136/bmjopen-2018-023042.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Rhee MY, Yang SJ, Oh SW, Park Y, Kim CI, Park HK, et al. Novel genetic variations associated with salt sensitivity in the Korean population. Hypertens Res. 2011;34(5):606–11. https://doi.org/10.1038/hr.2010.278.

    Article  CAS  PubMed  Google Scholar 

  58. Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero JJ, Chan W, et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis. 2020;76(3 Suppl 1):S1–S107. https://doi.org/10.1053/j.ajkd.2020.05.006.

    Article  CAS  PubMed  Google Scholar 

  59. Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH, et al. Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3):559–69. https://doi.org/10.1016/j.kint.2020.10.026.

    Article  PubMed  Google Scholar 

  60. Schweda F. Salt feedback on the renin-angiotensin-aldosterone system. Pflugers Arch. 2015;467(3):565–76. https://doi.org/10.1007/s00424-014-1668-y.

    Article  CAS  PubMed  Google Scholar 

  61. Kotchen TA, Cowley AW Jr, Frohlich ED. Salt in health and disease—a delicate balance. N Engl J Med. 2013;368(26):2531–2. https://doi.org/10.1056/NEJMc1305326.

    Article  PubMed  Google Scholar 

  62. Dinh QN, Drummond GR, Sobey CG, Chrissobolis S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int. 2014;2014:406960. https://doi.org/10.1155/2014/406960.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Sanghavi S, Vassalotti JA. Dietary sodium: a therapeutic target in the treatment of hypertension and CKD. J Ren Nutr. 2013;23(3):223–7. https://doi.org/10.1053/j.jrn.2013.01.027.

    Article  CAS  PubMed  Google Scholar 

  64. Zhao L, Stamler J, Yan LL, Zhou B, Wu Y, Liu K, et al. Blood pressure differences between northern and southern Chinese: role of dietary factors: the International Study on Macronutrients and Blood Pressure. Hypertension. 2004;43(6):1332–7. https://doi.org/10.1161/01.HYP.0000128243.06502.bc.

    Article  CAS  PubMed  Google Scholar 

  65. Ma G. The salt consumption of resident in China. Chinese J Prev Control Chronic Dis. 2008;16(4):214–7.

    Google Scholar 

  66. Shao S, Hua Y, Yang Y, Liu X, Fan J, Zhang A, et al. Salt reduction in China: a state-of-the-art review. Risk Manag Healthc Policy. 2017;10:17–28. https://doi.org/10.2147/RMHP.S75918.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Zhai FY, Du SF, Wang ZH, Zhang JG, Du WW, Popkin BM. Dynamics of the Chinese diet and the role of urbanicity, 1991-2011. Obes Rev. 2014;15(Suppl 1):16–26. https://doi.org/10.1111/obr.12124.

    Article  PubMed  Google Scholar 

  68. Health Promotion Board GoS. National Nutrition Survey 2010. 2010.

    Google Scholar 

  69. Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;3(12):e003733. https://doi.org/10.1136/bmjopen-2013-003733.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Chan GC, Teo BW, Tay JC, Chen CH, Cheng HM, Wang TD, et al. Hypertension in a multi-ethnic Asian population of Singapore. J Clin Hypertens (Greenwich). 2021;23(3):522–8. https://doi.org/10.1111/jch.14140.

    Article  CAS  Google Scholar 

  71. He FJ, Li J, Macgregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2013;(4):CD004937. https://doi.org/10.1002/14651858.CD004937.pub2.

  72. de Brito-Ashurst I, Perry L, Sanders TA, Thomas JE, Dobbie H, Varagunam M, et al. The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial. Heart. 2013;99(17):1256–60. https://doi.org/10.1136/heartjnl-2013-303688.

    Article  PubMed  Google Scholar 

  73. Konishi Y, Okada N, Okamura M, Morikawa T, Okumura M, Yoshioka K, et al. Sodium sensitivity of blood pressure appearing before hypertension and related to histological damage in immunoglobulin a nephropathy. Hypertension. 2001;38(1):81–5. https://doi.org/10.1161/01.hyp.38.1.81.

    Article  CAS  PubMed  Google Scholar 

  74. McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, et al. A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol. 2013;24(12):2096–103. https://doi.org/10.1681/ASN.2013030285.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Meuleman Y, Hoekstra T, Dekker FW, Navis G, Vogt L, van der Boog PJM, et al. Sodium restriction in patients with CKD: a randomized controlled trial of self-management support. Am J Kidney Dis. 2017;69(5):576–86. https://doi.org/10.1053/j.ajkd.2016.08.042.

    Article  CAS  PubMed  Google Scholar 

  76. Saran R, Padilla RL, Gillespie BW, Heung M, Hummel SL, Derebail VK, et al. A randomized crossover trial of dietary sodium restriction in stage 3-4 CKD. Clin J Am Soc Nephrol. 2017;12(3):399–407. https://doi.org/10.2215/CJN.01120216.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Slagman MC, Waanders F, Hemmelder MH, Woittiez AJ, Janssen WM, Lambers Heerspink HJ, et al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ. 2011;343:d4366. https://doi.org/10.1136/bmj.d4366.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol. 2008;19(5):999–1007. https://doi.org/10.1681/ASN.2007060693.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Xu J, Wang M, Chen Y, Zhen B, Li J, Luan W, et al. Estimation of salt intake by 24-hour urinary sodium excretion: a cross-sectional study in Yantai, China. BMC Public Health. 2014;14:136. https://doi.org/10.1186/1471-2458-14-136.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Jardine MJ, Li N, Ninomiya T, Feng X, Zhang J, Shi J, et al. Dietary sodium reduction reduces albuminuria: a cluster randomized trial. J Ren Nutr. 2019;29(4):276–84. https://doi.org/10.1053/j.jrn.2018.10.009.

    Article  CAS  PubMed  Google Scholar 

  81. Evans RG, Subasinghe AK, Busingye D, Srikanth VK, Kartik K, Kalyanram K, et al. Renal and dietary factors associated with hypertension in a setting of disadvantage in rural India. J Hum Hypertens. 2021. https://doi.org/10.1038/s41371-020-00473-5.

  82. Koh KH, Wei-Soon LH, Jun L, Lui-Sian LN, Hui-Hong CT. Study of low salt diet in hypertensive patients with chronic kidney disease. Med J Malaysia. 2018;73(6):376–81.

    CAS  PubMed  Google Scholar 

  83. Wakasugi M, James Kazama J, Narita I. Associations between the intake of miso soup and Japanese pickles and the estimated 24-hour urinary sodium excretion: a population-based cross-sectional study. Intern Med. 2015;54(8):903–10. https://doi.org/10.2169/internalmedicine.54.4336.

    Article  CAS  PubMed  Google Scholar 

  84. Health Research and Development Agency MoHRoI. Basic Health Research Report. 2018.

    Google Scholar 

  85. Teo BW, Bagchi S, Xu H, Toh QC, Li J, Lee EJ. Dietary sodium intake in a multiethnic Asian population of healthy participants and chronic kidney disease patients. Singap Med J. 2014;55(12):652–5. https://doi.org/10.11622/smedj.2014180.

    Article  Google Scholar 

  86. Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16(2):97–103. https://doi.org/10.1038/sj.jhh.1001307.

    Article  CAS  PubMed  Google Scholar 

  87. Amano H, Kobayashi S, Terawaki H, Ogura M, Kawaguchi Y, Yokoo T. Measurement of daily sodium excretion in patients with chronic kidney disease; special reference to the difference between the amount measured from 24 h collected urine sample and the estimated amount from a spot urine. Ren Fail. 2018;40(1):238–42. https://doi.org/10.1080/0886022X.2018.1456452.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Mun KH, Yu GI, Choi BY, Kim MK, Shin MH, Shin DH. Association of dietary potassium intake with the development of chronic kidney disease and renal function in patients with mildly decreased kidney function: the Korean Multi-Rural Communities Cohort Study. Med Sci Monit. 2019;25:1061–70. https://doi.org/10.12659/MSM.913504.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Kim J, Lee J, Kim KN, Oh KH, Ahn C, Lee J, et al. Association between dietary mineral intake and chronic kidney disease: the Health Examinees (HEXA) Study. Int J Environ Res Public Health. 2018;15(6):1070. https://doi.org/10.3390/ijerph15061070.

    Article  CAS  PubMed Central  Google Scholar 

  90. Sacks FM, Obarzanek E, Windhauser MM, Svetkey LP, Vollmer WM, McCullough M, et al. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure. Ann Epidemiol. 1995;5(2):108–18. https://doi.org/10.1016/1047-2797(94)00055-x.

    Article  CAS  PubMed  Google Scholar 

  91. Svetkey LP, Sacks FM, Obarzanek E, Vollmer WM, Appel LJ, Lin PH, et al. The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group. J Am Diet Assoc. 1999;99(8 Suppl):S96–104. https://doi.org/10.1016/s0002-8223(99)00423-x.

    Article  CAS  PubMed  Google Scholar 

  92. Lee HS, Lee KB, Hyun YY, Chang Y, Ryu S, Choi Y. DASH dietary pattern and chronic kidney disease in elderly Korean adults. Eur J Clin Nutr. 2017;71(6):755–61. https://doi.org/10.1038/ejcn.2016.240.

    Article  CAS  PubMed  Google Scholar 

  93. Jhee JH, Kee YK, Park JT, Chang TI, Kang EW, Yoo TH, et al. A diet rich in vegetables and fruit and incident CKD: a community-based prospective cohort study. Am J Kidney Dis. 2019;74(4):491–500. https://doi.org/10.1053/j.ajkd.2019.02.023.

    Article  PubMed  Google Scholar 

  94. Lew QJ, Jafar TH, Koh HW, Jin A, Chow KY, Yuan JM, et al. Red meat intake and risk of ESRD. J Am Soc Nephrol. 2017;28(1):304–12. https://doi.org/10.1681/ASN.2016030248.

    Article  PubMed  Google Scholar 

  95. Song Y, Lobene AJ, Wang Y, Hill Gallant KM. The DASH diet and cardiometabolic health and chronic kidney disease: a narrative review of the evidence in East Asian countries. Nutrients. 2021;13(3):984. https://doi.org/10.3390/nu13030984.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Zhang W, Shi W, Liu Z, Gu Y, Chen Q, Yuan W, et al. A nationwide cross-sectional survey on prevalence, management and pharmacoepidemiology patterns on hypertension in Chinese patients with chronic kidney disease. Sci Rep. 2016;6:38768. https://doi.org/10.1038/srep38768.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Teo BW, Chua HR, Wong WK, Haroon S, Subramanian S, Loh PT, et al. Blood pressure and antihypertensive medication profile in a multiethnic Asian population of stable chronic kidney disease patients. Singap Med J. 2016;57(5):267–73. https://doi.org/10.11622/smedj.2016089.

    Article  Google Scholar 

  98. Jessani S, Bux R, Jafar TH. Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan—a community based cross-sectional study. BMC Nephrol. 2014;15:90. https://doi.org/10.1186/1471-2369-15-90.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, et al. Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol. 2010;14(6):558–70. https://doi.org/10.1007/s10157-010-0328-6.

    Article  PubMed  Google Scholar 

  100. Li PK, Garcia-Garcia G, Lui SF, Andreoli S, Fung WW, Hradsky A, et al. Kidney health for everyone everywhere-from prevention to detection and equitable access to care. Kidney Int. 2020;97(2):226–32. https://doi.org/10.1016/j.kint.2019.12.002.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Medicine, National University Hospital, Singapore, Singapore

    Gek Cher Chan

  2. Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

    Gek Cher Chan

  3. Department of Medicine and Therapeutics, Carol and Richard Yu Peritoneal Dialysis Research Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China

    Philip Kam-Tao Li

Authors
  1. Gek Cher Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip Kam-Tao Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gek Cher Chan .

Editor information

Editors and Affiliations

  1. Apollo Hospitals, Apollo Institute for Blood Pressure Management, Hyderabad, India

    C. Venkata S. Ram

  2. Head, Division of Nephrology Department of Medicine, Yong Loo Lin Sch of Med Natl Univ of Sin, Singapore, Singapore

    Boon Wee Jimmy Teo

  3. Department of Cardiology, Hero DMC Heart Institute, Dayanand Medical College, Ludhiana, Punjab, India

    Gurpreet S. Wander

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chan, G.C., Li, P.KT. (2022). Hypertension and Chronic Kidney Disease in Asians. In: Ram, C.V.S., Teo, B.W.J., Wander, G.S. (eds) Hypertension and Cardiovascular Disease in Asia. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-030-95734-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-95734-6_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-95733-9

  • Online ISBN: 978-3-030-95734-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation